LENZ
Income statement / Annual
Last year (2023), LENZ Therapeutics, Inc.'s total revenue was $0.00,
a decrease of 100.00% from the previous year.
In 2023, LENZ Therapeutics, Inc.'s net income was -$124.65 M.
See LENZ Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00
|
$15.00 M
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$2.41 M |
$8.35 M |
$734,000.00 |
$121,000.00 |
$0.00 |
| Gross Profit |
-$2.41 M |
$6.65 M |
-$734,000.00 |
-$121,000.00 |
$0.00 |
| Gross Profit Ratio |
0 |
0.44 |
0 |
0 |
0 |
| Research and Development
Expenses |
$29.73 M
|
$64.44 M
|
$37.93 M
|
$9.12 M
|
$0.00
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$40.97 M
|
$32.85 M
|
$21.78 M
|
$4.26 M
|
$29,000.00
|
| Other Expenses |
$0.00 |
$19,000.00 |
-$869,000.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$70.70 M |
$97.29 M |
$59.71 M |
$13.38 M |
$29,000.00 |
| Cost And Expenses |
$73.11 M |
$105.64 M |
$60.44 M |
$13.50 M |
$29,000.00 |
| Interest Income |
$10.95 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$0.00 |
$0.00 |
$0.00 |
$40,000.00 |
$80,000.00 |
| Depreciation &
Amortization |
$2.41 M
|
$8.35 M
|
$734,000.00
|
$121,000.00
|
$171,860.00
|
| EBITDA |
-$122.24 M
|
-$97.29 M
|
-$70.03 M
|
-$68.21 M
|
-$29,000.00
|
| EBITDA Ratio |
0 |
-6.49 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
-7.04
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
-$51.54 M
|
$4.59 M
|
-$10.32 M
|
-$54.87 M
|
-$80,000.00
|
| Income Before Tax |
-$124.65 M |
-$101.05 M |
-$70.76 M |
-$68.37 M |
-$109,000.00 |
| Income Before Tax Ratio
|
0
|
-6.74
|
0
|
0
|
0
|
| Income Tax Expense |
-$124.65 M |
$347,000.00 |
$497,442.00 |
$0.00 |
-$171,860.00 |
| Net Income |
-$124.65 M |
-$101.05 M |
-$70.76 M |
-$68.37 M |
-$109,000.00 |
| Net Income Ratio |
0 |
-6.74 |
0 |
0 |
0 |
| EPS |
-15.3 |
-12.8908 |
-8.5384 |
-8.24 |
-0.0131 |
| EPS Diluted |
-15.3 |
-12.8908 |
-8.5384 |
-8.24 |
-0.0131 |
| Weighted Average Shares
Out |
$8.15 M
|
$7.84 M
|
$8.29 M
|
$8.30 M
|
$8.30 M
|
| Weighted Average Shares
Out Diluted |
$8.15 M
|
$7.84 M
|
$8.29 M
|
$8.30 M
|
$8.30 M
|
| Link |
|
|
|
|
|
